Lee SM - Search Results

1

Treatment outcome and prognostic factors for relapse after high-dose chemotherapy and peripheral blood stem cell rescue for patients with poor risk high grade non-Hodgkin's lymphoma.

Lee SM, Ryder WD, Clemons MJ, Morgenstern GR, Chang J, Scarffe JH, Radford JA. Lee SM, et al. Bone Marrow Transplant. 1999 Aug;24(3):271-7. doi: 10.1038/sj.bmt.1701894. Bone Marrow Transplant. 1999. PMID: 10455365

2

Cyclophosphamide decreases O6-alkylguanine-DNA alkyltransferase activity in peripheral lymphocytes of patients undergoing bone marrow transplantation.

Lee SM, Crowther D, Scarffe JH, Dougal M, Elder RH, Rafferty JA, Margison GP. Lee SM, et al. Br J Cancer. 1992 Aug;66(2):331-6. doi: 10.1038/bjc.1992.265. Br J Cancer. 1992. PMID: 1387001 Free PMC article.

3

Dacarbazine and interferon-alpha 2a in advanced malignant melanoma: high response rate and prolongation of response duration occur in different patient subpopulations.

Betticher DC, Lee SM, Morris C, Clemons M, Thatcher N. Betticher DC, et al. Among authors: lee sm. Melanoma Res. 1995 Aug;5(4):277-82. doi: 10.1097/00008390-199508000-00012. Melanoma Res. 1995. PMID: 7496165 Clinical Trial.

4

Melanoma: chemotherapy.

Lee SM, Betticher DC, Thatcher N. Lee SM, et al. Br Med Bull. 1995 Jul;51(3):609-30. doi: 10.1093/oxfordjournals.bmb.a072982. Br Med Bull. 1995. PMID: 7552084 Review.

5

Chemotherapy in non-small cell lung cancer.

Thatcher N, Ranson M, Lee SM, Niven R, Anderson H. Thatcher N, et al. Among authors: lee sm. Ann Oncol. 1995;6 Suppl 1:83-94; discussion 94-5. doi: 10.1093/annonc/6.suppl_1.s83. Ann Oncol. 1995. PMID: 8695551 Review.

6

Prognostic factors for disease progression in advanced Hodgkin's disease: an analysis of patients aged under 60 years showing no progression in the first 6 months after starting primary chemotherapy.

Lee SM, Radford JA, Ryder WD, Collins CD, Deakin DP, Crowther D. Lee SM, et al. Br J Cancer. 1997;75(1):110-5. doi: 10.1038/bjc.1997.18. Br J Cancer. 1997. PMID: 9000607 Free PMC article.

7

Dose intensity in small cell lung cancer.

Thatcher N, Lee SM, Woll PJ, Middleton M, Anderson H, Burt P, Stout R. Thatcher N, et al. Among authors: lee sm. Semin Oncol. 1998 Apr;25(2 Suppl 4):12-8; discussion 45-8. Semin Oncol. 1998. PMID: 9578057 Review.

8

Recombinant human granulocyte colony-stimulating factor (filgrastim) following high-dose chemotherapy and peripheral blood progenitor cell rescue in high-grade non-Hodgkin's lymphoma: clinical benefits at no extra cost.

Lee SM, Radford JA, Dobson L, Huq T, Ryder WD, Pettengell R, Morgenstern GR, Scarffe JH, Crowther D. Lee SM, et al. Br J Cancer. 1998 Apr;77(8):1294-9. doi: 10.1038/bjc.1998.216. Br J Cancer. 1998. PMID: 9579836 Free PMC article. Clinical Trial.

9

Patterns of relapse and subsequent management following high-dose chemotherapy with autologous haematopoietic support in relapsed or refractory Hodgkin's lymphoma: a two centre study.

Shamash J, Lee SM, Radford JA, Rohatiner AZ, Chang J, Morgenstern GR, Scarffe JH, Deakin DP, Lister TA. Shamash J, et al. Among authors: lee sm. Ann Oncol. 2000 Jun;11(6):715-9. doi: 10.1023/a:1008362700606. Ann Oncol. 2000. PMID: 10942061 Free article.

10

Use of hematopoietic progenitors in whole blood to support dose-dense chemotherapy: a randomized phase II trial in small-cell lung cancer patients.

Woll PJ, Thatcher N, Lomax L, Hodgetts J, Lee SM, Burt PA, Stout R, Simms T, Davies R, Pettengell R. Woll PJ, et al. Among authors: lee sm. J Clin Oncol. 2001 Feb 1;19(3):712-9. doi: 10.1200/JCO.2001.19.3.712. J Clin Oncol. 2001. PMID: 11157022 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

5,915 results

Search Page